Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18769488 | GUM AND TOOTH TREATMENT METHOD WITH RINSING | July 2024 | October 2024 | Allow | 3 | 1 | 0 | No | No |
| 18600658 | TREATMENT METHOD FOR TEETH AND GUMS | March 2024 | May 2024 | Allow | 3 | 0 | 0 | No | No |
| 18431648 | Composition for the control of oral malodor compounds | February 2024 | December 2024 | Abandon | 11 | 1 | 0 | No | No |
| 18459268 | PEROXIDE GEL COMPOSITIONS | August 2023 | July 2024 | Abandon | 11 | 1 | 0 | No | No |
| 18234068 | DUAL COMPONENT ORAL COMPOSITION FOR ENHANCING REMINERALIZATION OF TEETH | August 2023 | April 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18348960 | PEROXIDE GEL COMPOSITIONS | July 2023 | July 2024 | Abandon | 13 | 2 | 0 | No | No |
| 18337857 | PROCESS FOR PRODUCING A BIO-BASED SURFACTANT | June 2023 | June 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18322979 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | May 2023 | March 2025 | Allow | 21 | 2 | 0 | No | No |
| 18189892 | CALCIUM CARBONATE AND ZINC OXIDE-LOADED MICROCAPSULES AND USES THEREOF | March 2023 | April 2024 | Abandon | 12 | 1 | 1 | No | No |
| 18095800 | LASER ASSISTED WOUND HEALING PROTOCOL AND SYSTEM | January 2023 | March 2024 | Abandon | 14 | 1 | 0 | No | No |
| 18149989 | STABILIZED STANNOUS COMPOSITIONS | January 2023 | October 2024 | Allow | 22 | 1 | 1 | No | No |
| 18072437 | lntraoral Cleaning Tablet | November 2022 | March 2025 | Abandon | 28 | 2 | 1 | No | No |
| 18049843 | PEROXIDE GEL COMPOSITIONS | October 2022 | October 2023 | Allow | 12 | 1 | 0 | No | No |
| 17949366 | Composition for the control of oral malodor compounds | September 2022 | December 2024 | Allow | 26 | 6 | 0 | Yes | No |
| 17752568 | ALIPHATIC ANIONIC COMPOUNDS AND OXIDATIVE COMPOUNDS WITH IMPROVED STABILITY AND EFFICACY FOR USE IN PHARMACEUTICAL COMPOSITIONS | May 2022 | March 2025 | Abandon | 33 | 0 | 1 | No | No |
| 17752543 | Oral Care Compositions | May 2022 | April 2023 | Allow | 11 | 2 | 0 | No | Yes |
| 17735034 | LASER ASSISTED WOUND HEALING PROTOCOL AND SYSTEM | May 2022 | March 2023 | Allow | 11 | 1 | 0 | No | No |
| 17659473 | PEROXIDE GEL COMPOSITIONS | April 2022 | September 2023 | Allow | 17 | 2 | 0 | No | No |
| 17698618 | Dentifrice Composition Comprising Zinc Oxide and Zinc Citrate | March 2022 | January 2024 | Abandon | 22 | 2 | 0 | No | No |
| 17566660 | Oral concentrate additive masking mixute | March 2022 | April 2024 | Abandon | 27 | 1 | 0 | No | No |
| 17591750 | Silver Fluoride Formulations, Methods and Devices for Caries Management | February 2022 | November 2023 | Allow | 21 | 4 | 0 | Yes | No |
| 17648608 | Dental formulation comprising xylitol and propolis | January 2022 | February 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17557560 | Peroxide Gel Compositions | December 2021 | August 2024 | Abandon | 32 | 2 | 1 | No | No |
| 17643818 | TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF | December 2021 | August 2023 | Allow | 20 | 3 | 0 | No | No |
| 17643820 | TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF | December 2021 | September 2023 | Allow | 21 | 2 | 0 | No | No |
| 17545205 | METHODS AND COMPOSITIONS FOR DENTAL TISSUE REPAIR AND/OR REGENERATION | December 2021 | February 2024 | Abandon | 27 | 0 | 1 | No | No |
| 17604011 | SCUTELLARIA COMPOSITIONS AND METHODS FOR TASTE MODULATION | October 2021 | April 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17478635 | COMPOSITIONS AND METHODS OF USING SUCH COMPOSITIONS AS AN ORAL RINSE | September 2021 | April 2025 | Abandon | 43 | 2 | 1 | No | No |
| 17476189 | Oral Care Compositions | September 2021 | May 2023 | Abandon | 20 | 1 | 0 | No | No |
| 17435314 | ORAL CARE PRODUCT | August 2021 | June 2024 | Allow | 33 | 5 | 0 | Yes | No |
| 17434731 | STABILISED HYPOCHLOROUS SOLUTIONS AND THEIR MEDICAL COSMETIC USES | August 2021 | April 2022 | Allow | 8 | 1 | 0 | No | No |
| 17422728 | FORMULATIONS CONTAINING ACTIVE OXYGEN COMPOUNDS AND DEVICES FOR APPLICATION THEREOF | July 2021 | December 2024 | Allow | 41 | 4 | 1 | Yes | No |
| 17365630 | Preparation for Attaching to Teeth or Surrounding Part of Teeth | July 2021 | June 2024 | Abandon | 35 | 2 | 0 | Yes | No |
| 17309858 | Methods of Inhibiting Neutrophil Recruitment to the Gingival Crevice | June 2021 | April 2025 | Allow | 46 | 2 | 0 | No | No |
| 17416254 | AQUEOUS GELS FOR DYEING OR MAKING UP THE EYEBROWS | June 2021 | November 2024 | Abandon | 41 | 1 | 1 | No | No |
| 17415209 | ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND BIPHENOL | June 2021 | May 2025 | Abandon | 47 | 1 | 1 | No | No |
| 17296627 | COMPOUNDS WITH HIV MATURATION INHIBITORY ACTIVITY | May 2021 | September 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17302084 | Stannous Salt And Sodium Tripolyphosphate Oral Care Compositions And Methods | April 2021 | April 2023 | Abandon | 23 | 1 | 0 | No | No |
| 17302095 | Stannous Salt And Sodium Tripolyphosphate Oral Care Compositions And Methods | April 2021 | July 2023 | Allow | 27 | 2 | 0 | No | No |
| 17229479 | PHARMACEUTICAL COMPOSITIONS | April 2021 | September 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17224347 | NOVEL COMPOSITION | April 2021 | March 2023 | Allow | 24 | 1 | 0 | No | No |
| 17214731 | Oral Care Compositions and Methods of Use | March 2021 | October 2023 | Allow | 31 | 2 | 0 | No | No |
| 17279152 | COMPOSITIONS AND METHODS FOR REDUCING CALCIFICATION OF HEART VALVES | March 2021 | March 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17210180 | Methods for Manufacturing Arginine Dentifrice | March 2021 | October 2024 | Allow | 43 | 4 | 0 | No | No |
| 17209293 | SYSTEMS, METHODS AND COMPOSITIONS FOR EFFECTIVE SANITIZING OR DISINFECTING | March 2021 | October 2023 | Abandon | 31 | 1 | 1 | No | No |
| 17278301 | PROCESS FOR PRODUCING A BIO-BASED SURFACTANT | March 2021 | July 2023 | Abandon | 28 | 2 | 0 | No | No |
| 17269982 | ORAL COMPOSITIONS | February 2021 | October 2024 | Allow | 44 | 1 | 1 | No | No |
| 17269428 | ORAL RINSE COMPOSITIONS FOR REDUCING PATHOGENS UNDERLYING AND FOR TREATING PERIODONTAL DISEASE AND ORAL MALODOR IN THE CANINE | February 2021 | September 2024 | Abandon | 43 | 2 | 1 | No | No |
| 17175869 | USE OF STATINS FOR PERIODONTAL DISEASE AND BONE REGENERATION | February 2021 | October 2022 | Abandon | 20 | 1 | 0 | No | No |
| 17174698 | ORAL CARE COMPOSITION | February 2021 | July 2024 | Allow | 41 | 5 | 0 | Yes | No |
| 17169012 | STABILIZED STANNOUS COMPOSITIONS | February 2021 | September 2022 | Allow | 20 | 1 | 0 | No | No |
| 17259228 | FUNGICIDES TO PREVENT AND CONTROL FUNGAL PATHOGENS | January 2021 | August 2024 | Allow | 43 | 2 | 1 | Yes | Yes |
| 17256517 | Vegetable Paper Comprising Bast Fibres and Cosmetic Products Made Thereof | December 2020 | June 2023 | Allow | 30 | 2 | 1 | No | No |
| 17254089 | COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF FIBROSIS | December 2020 | January 2025 | Abandon | 49 | 1 | 1 | No | No |
| 17247099 | Oral Care Compositions | November 2020 | March 2023 | Allow | 28 | 3 | 0 | No | No |
| 17057891 | ALCOHOL-FREE BOTANICAL ORAL CARE PRODUCTS | November 2020 | March 2023 | Abandon | 28 | 1 | 1 | No | No |
| 17057155 | SHARK TEETH BIOCERAMICS AND USES THEREOF | November 2020 | August 2023 | Abandon | 33 | 1 | 1 | No | No |
| 16951869 | TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF | November 2020 | May 2021 | Allow | 6 | 1 | 0 | Yes | No |
| 17055192 | TABLETS CONTAINING POLYPHOSPHATES | November 2020 | May 2025 | Abandon | 54 | 4 | 0 | Yes | Yes |
| 17054611 | ORAL HYGIENE COMPOSITIONS FOR PREVENTING THE FORMATION OF ORAL BIOFILMS AND PROCESS FOR PREPARING THE SAME | November 2020 | February 2025 | Allow | 51 | 4 | 1 | No | No |
| 17094489 | N-ACYL SARCOSINATE COMPOUNDS AND OXIDATIVE COMPOUNDS WITH IMPROVED STABILITY AND EFFICACY FOR USE IN PHARMACEUTICAL COMPOSITIONS | November 2020 | June 2022 | Allow | 20 | 1 | 0 | Yes | No |
| 17092304 | MEDICAL IMPLANTS CONTAINING SURFACE MODIFIED WITH GOLD NANOPARTICLES | November 2020 | December 2024 | Allow | 49 | 1 | 1 | No | No |
| 17090078 | BIOACTIVE POLYMER FOR BONE REGENERATION | November 2020 | September 2024 | Allow | 46 | 3 | 1 | Yes | No |
| 17049110 | COSMETIC COMPOSITION OF NON-AQUEOUS THIXOTROPIC NAIL VARNISH CONTAINING A NAIL-HARDENING AGENT, USE AND IMPLEMENTATION METHOD | October 2020 | August 2024 | Abandon | 46 | 4 | 1 | No | No |
| 17037766 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | September 2020 | March 2023 | Allow | 30 | 3 | 0 | Yes | No |
| 17037776 | Oral Care Compositions Comprising Hops Beta Acids And Metal Ions | September 2020 | February 2023 | Allow | 29 | 3 | 0 | Yes | No |
| 17035863 | ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL AMINO ACID, AND POLYPHOSPHATE | September 2020 | June 2022 | Allow | 21 | 2 | 0 | Yes | No |
| 17012350 | DUAL MATERIAL IMPLANT | September 2020 | August 2024 | Allow | 48 | 3 | 1 | No | No |
| 17009318 | PHARMACEUTICAL COMPOSITIONS COMPRISING HEPARINOIDS AND METHODS FOR PREPARING THEREOF | September 2020 | February 2023 | Abandon | 30 | 1 | 1 | No | No |
| 17008688 | Oral Care Compositions Comprising Metal Ions | September 2020 | October 2023 | Allow | 37 | 4 | 0 | No | No |
| 17009149 | Enhanced Toothpaste And Kits | September 2020 | September 2023 | Allow | 36 | 3 | 1 | Yes | No |
| 17007859 | STYLING COMPOSITION FOR TEMPORARILY DEFORMING KERATINOUS FIBERS AND ITS USE | August 2020 | January 2023 | Abandon | 28 | 2 | 0 | No | No |
| 16955923 | DEVICE FOR MAINTAINING METAL HOMEOSTASIS, AND USES THEREOF | August 2020 | April 2025 | Abandon | 58 | 2 | 1 | No | No |
| 16928489 | TEETH WHITENING PRODUCT CONTAINING PIEZOELECTRIC MATERIAL | July 2020 | June 2024 | Abandon | 48 | 2 | 2 | No | No |
| 16962040 | PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE DELIVERY OF BUPRENORPHINE | July 2020 | June 2022 | Allow | 23 | 2 | 0 | No | No |
| 16924647 | MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND METHODS FOR THE TREATMENT OF DENTAL DISEASE | July 2020 | February 2023 | Allow | 31 | 2 | 1 | No | No |
| 16917731 | Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions | June 2020 | June 2022 | Abandon | 24 | 1 | 0 | No | No |
| 16959186 | PHENYLPROPIONATE COMPOUND, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF | June 2020 | April 2023 | Allow | 34 | 2 | 1 | No | No |
| 16958739 | PYRAZOLAMIDE COMPOUND HAVING INSECTICIDAL ACTIVITY AND USE THEREOF | June 2020 | March 2023 | Abandon | 33 | 2 | 1 | Yes | No |
| 16959127 | METHOD TO PREPARE A FILLER WITH A HYALURONIC ACID BASE | June 2020 | July 2022 | Allow | 25 | 1 | 0 | No | No |
| 16958881 | USE OF CHLOROGENIC ACID IN PREPARATION OF DRUG FOR TREATING CHORDOMA | June 2020 | September 2022 | Allow | 27 | 2 | 0 | Yes | No |
| 16958140 | INDOMETHACIN MENTHYL ESTER-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | June 2020 | August 2022 | Abandon | 26 | 1 | 1 | No | No |
| 16957577 | COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION | June 2020 | October 2022 | Abandon | 27 | 2 | 1 | No | No |
| 16911369 | METHODS TO TREAT INFLAMMATORY AND SMOOTH MUSCLE CELL PROLIFERATION DISORDERS | June 2020 | March 2025 | Abandon | 56 | 5 | 1 | No | No |
| 16957425 | Personal Care Compositions | June 2020 | March 2024 | Allow | 45 | 4 | 0 | Yes | No |
| 16898466 | Kits Comprising Unit-Dose Oral Care Compositions | June 2020 | November 2024 | Allow | 53 | 5 | 1 | No | No |
| 16946132 | TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF | June 2020 | July 2021 | Allow | 13 | 1 | 0 | Yes | No |
| 16877500 | ORAL HYGIENE DROPLETS | May 2020 | March 2023 | Abandon | 34 | 2 | 0 | No | No |
| 16763068 | THICKENER SYSTEMS FOR ORAL CARE COMPOSITIONS AND A METHOD FOR PREPARING THE SAME | May 2020 | October 2023 | Allow | 41 | 4 | 1 | Yes | No |
| 16859288 | Low Water Stannous Fluoride Plus Zinc Citrate Dentifrice with Improved Stability, Rheology, and Efficacy | April 2020 | November 2021 | Allow | 19 | 1 | 0 | No | No |
| 16833092 | Resurrection Of Antibiotics That MRSA Resists By Silver-Doped Bioactive Glass-Ceramic Particles | March 2020 | October 2023 | Allow | 42 | 3 | 1 | Yes | No |
| 16832603 | ORAL COMPOSITION | March 2020 | October 2020 | Allow | 7 | 1 | 0 | No | No |
| 16828326 | Oral Care Compositions | March 2020 | July 2023 | Allow | 39 | 4 | 1 | No | No |
| 16796440 | STABLE ANHYDROUS TOOTHPASTE CONCENTRATE FORMULATION AND METHOD OF MAKING SAME | February 2020 | February 2022 | Abandon | 24 | 1 | 1 | No | No |
| 16784563 | Peroxide Gel Composition | February 2020 | January 2021 | Abandon | 11 | 1 | 0 | No | No |
| 16784582 | Peroxide Gel Composition | February 2020 | November 2021 | Allow | 22 | 2 | 0 | No | No |
| 16784086 | COSMETIC AND TOPICAL COMPOSITIONS COMPRISING CANNABIGEROL | February 2020 | June 2022 | Abandon | 28 | 2 | 0 | No | No |
| 16781388 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS | February 2020 | December 2021 | Allow | 22 | 3 | 0 | Yes | No |
| 16777936 | Oral Care Compositions and Methods of Use | January 2020 | August 2021 | Allow | 19 | 1 | 0 | No | No |
| 16737132 | Oral Care Compositions and Methods of Use | January 2020 | May 2023 | Abandon | 40 | 6 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBERTS, LEZAH.
With a 9.2% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 14.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ROBERTS, LEZAH works in Art Unit 1612 and has examined 769 patent applications in our dataset. With an allowance rate of 46.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner ROBERTS, LEZAH's allowance rate of 46.3% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ROBERTS, LEZAH receive 3.05 office actions before reaching final disposition. This places the examiner in the 96% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ROBERTS, LEZAH is 41 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +37.3% benefit to allowance rate for applications examined by ROBERTS, LEZAH. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 17.8% of applications are subsequently allowed. This success rate is in the 9% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 21.1% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 47.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 39% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 53.9% of appeals filed. This is in the 20% percentile among all examiners. Of these withdrawals, 55.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 49.7% are granted (fully or in part). This grant rate is in the 59% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 82% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 7.3% of allowed cases (in the 84% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.